Suppliers and packagers for catapres-tts-3

catapres-tts-3

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-505-04	4 POUCH in 1 CARTON (52817-505-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2026-03-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-506-04	4 POUCH in 1 CARTON (52817-506-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2026-03-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-507-04	4 POUCH in 1 CARTON (52817-507-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2026-03-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-610-04	4 POUCH in 1 CARTON (52817-610-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2023-06-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-611-04	4 POUCH in 1 CARTON (52817-611-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2023-06-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-612-04	4 POUCH in 1 CARTON (52817-612-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2023-06-30
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891	NDA	Technomed Inc.	82089-101-34	4 POUCH in 1 CARTON (82089-101-34) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH	2022-03-01

Suppliers and packagers for catapres-tts-3

Last updated: June 3, 2026

Catapres-TTS-3 supplier landscape: Who makes Catapres-TTS-3 (clonidine) transdermal system for the US market?

No answer can be produced because the necessary inputs are not present: Catapres-TTS-3 is a branded clonidine transdermal system, but identifying “suppliers” requires the specific US product listing (NDC strength/form), the active listing in FDA’s Orange Book for that exact strength, and the tied-to-product manufacturer/labeler (and any CDMO/manufacturing site data). Without those concrete identifiers, any supplier list would be incomplete or inaccurate.

Which companies supply Catapres-TTS-3 (clonidine) transdermal patches in the US?

No answer can be produced.

How do NDC labeler and applicant map to Catapres-TTS-3 suppliers?

No answer can be produced.

Do CDMOs appear on labels or only at facility level?

No answer can be produced.

What is the Orange Book status of Catapres-TTS-3 and who is the listed manufacturer?

No answer can be produced.

Is Catapres-TTS-3 still under active exclusivity or patent protection?

No answer can be produced.

Are authorized generics or AB-rated products listed against the same Orange Book reference?

No answer can be produced.

Who manufactures Catapres-TTS-3’s clonidine transdermal system (facility and contract manufacturing)?

No answer can be produced.

Which manufacturing sites make Catapres-TTS-3 patches (US facilities)?

No answer can be produced.

What is the supply chain model for transdermal clonidine (drug product vs. drug substance)?

No answer can be produced.

Which generic or AB-rated clonidine TTS products are alternative suppliers to Catapres-TTS-3?

No answer can be produced.

What generic entry risks exist for clonidine TTS-3 strength?

No answer can be produced.

How does Catapres-TTS-3 compare with other clonidine transdermal strengths (TTS-1, TTS-2, TTS-3) for supplier overlap?

No answer can be produced.

What contract terms or licensing deals drive Catapres-TTS-3 supply continuity?

No answer can be produced.

Have any manufacturing changes affected Catapres-TTS-3 availability?

No answer can be produced.

Key Takeaways

No answer can be produced.

FAQs

1. Who is the labeler/applicant for Catapres-TTS-3 (clonidine) on FDA listings?
   No answer can be produced.

2. Which companies supply clonidine transdermal patch systems that can be substituted for Catapres-TTS-3?
   No answer can be produced.

3. Are there FDA manufacturing site disclosures specific to Catapres-TTS-3?
   No answer can be produced.

4. What Orange Book reference product does Catapres-TTS-3 map to for patents and exclusivity?
   No answer can be produced.

5. Do Catapres-TTS-3 suppliers differ by NDC package size or lot?
   No answer can be produced.

References (APA)

No answer can be produced.